BofA Downgrades LyondellBasell to Underperform Amid Cautious Outlook
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy LYB?
Source: seekingalpha
- Rating Downgrade Impact: Bank of America downgraded LyondellBasell from Neutral to Underperform, arguing that the recent stock price increase driven by geopolitical factors is already reflected in current valuations, indicating a cautious outlook on future profitability.
- Earnings Forecast Increase: Despite the downgrade, BofA raised its earnings forecasts for 2026-2028, expecting a significant increase in EBITDA for 2026, reflecting stronger product margins and elevated energy prices.
- Valuation Concerns: The report highlights that current stock prices already discount 'peak' earnings conditions, urging investors to be wary of the sustainability of profitability, especially as geopolitical effects fade and supply-demand balances normalize.
- Oversupply Risk: BofA warns of a potential re-emergence of oversupply risks in petrochemical markets if capacity closures do not materialize, as low global utilization rates and significant capacity additions, particularly in polyethylene, could pressure margins in the coming years.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy LYB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on LYB
Wall Street analysts forecast LYB stock price to fall
15 Analyst Rating
1 Buy
11 Hold
3 Sell
Hold
Current: 79.600
Low
36.00
Averages
47.29
High
57.00
Current: 79.600
Low
36.00
Averages
47.29
High
57.00
About LYB
LyondellBasell Industries N.V. is a global, independent chemical company creating solutions for everyday sustainable living. The Company's segments include Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), and Technology. The O&P-Americas and O&P-EAI segments produces and markets olefins and co-products, polyethylene, and polypropylene. The I&D segment produces and markets propylene oxide (PO) and its derivatives, oxyfuels and related products, and intermediate chemicals, such as styrene monomer (SM), and acetyls. The APS segment produces and markets compounding and solutions, such as polypropylene compounds, engineered plastics, masterbatches, engineered composites, colors, and powders. The Technology segment develops and licenses chemical and polyolefin process technologies and manufactures and sells polyolefin catalysts.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Announcement Schedule: LyondellBasell will release its Q1 2026 financial results before the U.S. market opens on May 1, providing investors with critical financial data and market performance insights.
- Webcast Details: Following the earnings release, LyondellBasell will host a webcast at 11 a.m. EDT, led by investor relations head David Kinney, offering in-depth financial analysis and future outlook.
- Replay Information: A replay of the call will be available from 1 p.m. EDT on May 1 until May 31, ensuring that investors who cannot attend live can access important information, thereby enhancing transparency.
- Company Background: LyondellBasell is a leader in the global chemical industry, committed to driving a circular economy through advanced technology and investments, producing high-quality polymers and innovative products for sustainable transportation, food safety, and more.
See More
- Rating Downgrade Impact: Bank of America downgraded LyondellBasell from Neutral to Underperform, arguing that the recent stock price increase driven by geopolitical factors is already reflected in current valuations, indicating a cautious outlook on future profitability.
- Earnings Forecast Increase: Despite the downgrade, BofA raised its earnings forecasts for 2026-2028, expecting a significant increase in EBITDA for 2026, reflecting stronger product margins and elevated energy prices.
- Valuation Concerns: The report highlights that current stock prices already discount 'peak' earnings conditions, urging investors to be wary of the sustainability of profitability, especially as geopolitical effects fade and supply-demand balances normalize.
- Oversupply Risk: BofA warns of a potential re-emergence of oversupply risks in petrochemical markets if capacity closures do not materialize, as low global utilization rates and significant capacity additions, particularly in polyethylene, could pressure margins in the coming years.
See More
- Market Performance: The S&P 500 rose by 0.27% and the Nasdaq 100 by 0.41%, reaching 1.5-week highs, reflecting market optimism over a potential ceasefire in Iran, although the feasibility of such an agreement remains uncertain.
- Economic Data Impact: The US March ISM services index fell to 54.0, below the expected 54.9, indicating signs of economic slowdown that could pressure the stock market, especially as investor confidence in recovery wanes.
- Strong Labor Market: Nonfarm payrolls increased by 178,000 in March, significantly surpassing the expected 65,000, while the unemployment rate unexpectedly dropped to 4.3%, demonstrating labor market resilience that may support the stock market.
- Oil Market Volatility: Crude oil prices are fluctuating amid Iran's rejection of a ceasefire and ongoing military actions, with the International Energy Agency warning that even if the war ends, normal flows through the Strait of Hormuz will take time to resume, potentially impacting global energy supply.
See More
- AppLovin Revenue Upgrade: BTIG raised AppLovin's first-quarter revenue estimate to $1.82 billion, exceeding consensus, reflecting healthier performance from non-gaming marketers, which is expected to drive further stock price appreciation.
- Encompass Health Surge: Shares of Encompass Health jumped over 6% after the Centers for Medicare & Medicaid Services proposed a 2.4% rate increase for fiscal year 2027, indicating positive policy changes for the healthcare sector.
- Kratos Defense Rallies 8%: Jefferies upgraded Kratos from hold to buy with a 12-month price target of $85, highlighting a $14 billion opportunity pipeline in weapons that could drive over 30% compound annual growth in 2028 earnings estimates.
- Soleno Therapeutics Soars 32%: Neurocrine Biosciences announced an agreement to acquire Soleno for $53 per share, valuing the deal at approximately $2.9 billion, which will enhance Neurocrine's leadership in endocrinology and rare diseases.
See More
- Market Movements: The S&P 500 Index rose by 0.19%, while the Dow Jones Industrial Average dipped by 0.04%, and the Nasdaq 100 Index increased by 0.50%, indicating slight fluctuations in the market amid strong economic data, reflecting cautious optimism among investors regarding future economic prospects.
- Strong Employment Data: March nonfarm payrolls surged by 178,000, significantly exceeding expectations of 65,000, and the unemployment rate unexpectedly fell by 0.1% to 4.3%, demonstrating resilience in the U.S. labor market, which may positively influence market sentiment.
- Declining Oil Prices: Crude oil prices fell by over 1% amid ceasefire negotiations in the Iran conflict, which could affect energy market stability; the International Energy Agency warned that even if the war ends, it will take time for normal flows through the Strait of Hormuz to resume, impacting global supply chains.
- Tech Stock Performance: Chipmakers and AI infrastructure stocks are climbing, with Seagate Technology's stock rising over 7%, showcasing ongoing market confidence in the tech sector, which may drive further investment and innovation in related companies.
See More
- Market Rebound Expectations: The S&P 500 rose on Monday amid hopes for a potential U.S.-Iran ceasefire, despite President Trump's threats of military action, as the market believes he may postpone the deadline, providing short-term optimism for investors.
- Wells Fargo Price Target Increase: Goldman Sachs raised Wells Fargo's price target from $93 to $96, with analysts stating the stock is well-positioned ahead of earnings; Jim Cramer advised against trimming positions at the current price of around $81, noting it is far from its all-time high.
- CrowdStrike Buyback Program Expansion: CrowdStrike increased its share buyback program by $500 million to $1.5 billion, viewing the stock's decline as an investment opportunity; Jim Cramer emphasized that the rise of AI actually increases the need for cybersecurity, countering market fears of AI disruption.
- Capital One Price Target Downgrade: Barclays cut Capital One's price target from $287 to $226, with Jim Cramer criticizing Wall Street analysts for underestimating the company's potential, particularly regarding the Discover acquisition and its undervalued stock price.
See More











